Project Description

Critical Changes to Co-Pay Assistance Programs in 2021

Jason Zemcik, Senior Director, Product Management
Rick Fry, Senior Vice President, Commercial Solutions


As October 2020 draws to a close, biopharmaceutical leaders are undoubtedly deep in the process of planning strategies to position their brands for a successful 2021. As the market landscape relative to co-pay assistance programs continues to evolve, it is important to address a number of critical areas that may impact these programs and possibly cause significant disruption if manufacturers do not have a practical strategy in place. This article provides insight into some of these areas along with informational resources to guide planning for your team.

Please submit the form below to view this resource.

Request Resource